Lung Cancer
Conditions
Interventions
case series:Nil
Sponsors
Shanghai Pulmonary Hospital Affiliated to Tongji University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 to 75 years. 2. The patients with small cell lung cancer were diagnosed by pathology. 3. The clinical stages of patients diagnosed as the first diagnosis in a wide range of imaging are in accordance with AJCC (Eighth Edition) diagnostic standard. 4. Patients with ECoG score of 0 or 1. 5. Patients who have not received immune regulators affecting the immune system in the last 3 months. 6. At least 1 patient with lesions that can be determined by recist1.1. 7. Patients who can be provided with tissue samples for TMB detection. 8. Patients who conform to NCCN guidelines and consensus of immunotherapy in China, and receive etilipzumab combined chemotherapy.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of infectious diseases in the past 3 months (including respiratory, digestive and genitourinary systems). 2. Patients with central nervous system metastasis symptoms. 3. Patients with autoimmune diseases or receiving systemic immunosuppressive therapy. 4. Patients who have been treated with corticosteroids or have a history of noninfectious pneumonia in recent 3 months. 5. Patients who received lung radiotherapy more than 30 Gy in the past 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective Response Rate;Disease Control Rate;Progression-Free Survival; | — |
Countries
China
Contacts
Public ContactWang Jiyin
Shanghai Pulmonary Hospital Affiliated to Tongji University
Outcome results
None listed